Alpha Cognition Inc
ACOG5.230USD
+0.170+3.36%
Fechamento 04/25, 16:00（ET）Cotações atrasadas em 15 min
83.78MValor de mercado
PerdaP/L TTM
Mais detalhes de Alpha Cognition Inc Empresa
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
Informações da empresa
Código da empresaACOG
Nome da EmpresaAlpha Cognition Inc
Data de listagemJun 09, 2021
Fundado em2017
CEOMr. Michael Mcfadden
Número de funcionários52
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 09
Endereçoc/o 1200 - 750 West Pender Street
CidadeVANCOUVER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalV6C 2T8
Telefone16045649244
Sitehttps://www.alphacognition.com/
Código da empresaACOG
Data de listagemJun 09, 2021
Fundado em2017
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: qui, 24 de abr
Tempo de atualização: qui, 24 de abr
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Estatísticas dos acionistas
Acionista
Proporção
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Tipo
Acionista
Proporção
Hedge Fund
31.49%
Investment Advisor/Hedge Fund
15.07%
Individual Investor
8.21%
Investment Advisor
2.23%
Corporation
1.38%
Bank and Trust
0.07%
Other
41.54%
Participação acionária institucional
Tempo de atualização: ter, 1 de abr
Tempo de atualização: ter, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
35
8.65M
54.08%
+8.55M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Solas Capital Management, LLC
1.39M
8.7%
+1.39M
--
Dec 31, 2024
AWM Investment Company, Inc.
1.05M
6.58%
+1.05M
--
Dec 31, 2024
Cable Car Capital LLC
514.72K
3.21%
+514.72K
--
Dec 31, 2024
Ikarian Capital LLC
755.87K
4.72%
+755.87K
--
Dec 31, 2024
Sphera Funds Management Ltd.
620.00K
3.87%
+620.00K
--
Dec 31, 2024
Sio Capital Management, LLC
434.70K
2.71%
+434.70K
--
Dec 31, 2024
Alyeska Investment Group, L.P.
400.00K
2.5%
+400.00K
--
Dec 31, 2024
Manchester Management Company, L.L.C.
379.34K
2.37%
+364.17K
+2.40K%
Nov 13, 2024
Havens (John P)
285.59K
1.78%
+274.34K
+2.44K%
Nov 13, 2024
Altium Capital Management LP
275.00K
1.72%
+275.00K
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados